Skip to main content
Log in

Effects of serum containing Chinese medicine Sanpi Pingwei (散癖平胃) formula on proliferation and apoptosis of human SGC-7901 cells

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To investigate the effects of serum containing Chinese medicine (CM) Sanpi Pingwei (散癖平胃, SPPW) formula on the proliferation and apoptosis of human SGC-7901 cells and the possible mechanism.

Methods

Serum containing CM SPPW formula (SPPW serum) was prepared by a serum pharmacology method. Human SGC-7901 cells were incubated with SPPW serum at three different concentrations and with the anticancer drug 5-fluorouracil (5-FU), respectively. Cell proliferation was assessed by MTT assay, and cell apoptosis was detected by flow cytometry assay. Real-time quantitative polymerase chain reaction (RT-PCR) and Western blot assay were employed to confirm the expressions of Bcl-2, Bax and p53 in SGC-7901 cells at mRNA and protein levels, respectively.

Results

SPPW serum suppressed the proliferation of SGC-7901 cells in a time- and dose-dependent manner. The colony forming rate of negative control was 48.2%, while those in the three SPPW serum groups and the 5-FU group decreased significantly (P<0.01). The number of colony forming units in the SPPW high dosage group was significantly smaller than that in the 5-FU group (P<0.01). MTT assay showed that SPPW serum restrained the proliferation of SGC-7901 cells, and the inhibition rate increased significantly in a dose-dependent manner. Annexin V/PI Assay suggested that SPPW serum induced the apoptosis of SGC-7901 cells significantly. RT-PCR and western blot assay indicated that SPPW serum upregulated the protein and mRNA expression levels of Bax and p53 in SGC-7901 cells, but downregulated the protein and mRNA expressions of Bcl-2.

Conclusions

SPPW formula inhibits the proliferation of SGC-7901 cells in vitro and induces the cell apoptosis. It plays an anticancer role by regulating the expressions of Bax, p53 and Bcl-2 in SGC-7901 cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Iacobuzio-Donahue CA, et al. Claudin-4, mitogenactivated protein kinase kinase 4, and stratifin aremarkers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev 2006;15:281–287.

    Article  PubMed  CAS  Google Scholar 

  2. Meireles SI, Cristo EB, Carvalho AF, Hirata R Jr, Pelosof A, Gomes LI, et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res 2004;64:1255–1265.

    Article  PubMed  CAS  Google Scholar 

  3. Valentini V, Cellini F, Minsky BD, Mattiucci GC, Balducci M, D’Agostino G, et al. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol 2009;92:176–183.

    Article  PubMed  Google Scholar 

  4. Varadhachary G, Ajani JA. Gastric cancer. Clin Adv Hematol Oncol 2005;3:118–124.

    PubMed  Google Scholar 

  5. Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, et al. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected highrisk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. Ann Oncol 2005;16:1326–1333.

    Article  PubMed  CAS  Google Scholar 

  6. Lin WL, Li DG, Chen Q, Lu HM. Clinical and experimental study of oxaliplatin in treating human gastric carcinoma. World J Gastroenterol 2004;10:2911–2915.

    PubMed  CAS  Google Scholar 

  7. Abe M, Nishimura Y, Shibamoto Y. Intraoperative radiation therapy for gastric cancer. World J Surg 1995;19:544–547.

    PubMed  CAS  Google Scholar 

  8. Klautke G, Foitzik T, Ludwig K, Ketterer P, Klar E, Fietkau R. Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma. Strahlenther Onkol 2004;180:695–700.

    Article  PubMed  Google Scholar 

  9. Zuo Y, Xu M, Shen D, Lu WD, Lu JF. Postoperative intraperitioneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patients. Chin J Oncol (Chin) 2004;26:247–249.

    Google Scholar 

  10. Bozzetti F, Vaglini M, Deraco M. Intraperitoneal hyperthermic chemotherapy in gastric cancer: rationale for a new approach. Tumor 1998;84:483–488.

    CAS  Google Scholar 

  11. Yamauchi K, Yang M, Hayashi K, Jiang P, Yamamoto N, Tsuchiya H. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res 2008;68:516–520.

    Article  PubMed  CAS  Google Scholar 

  12. Orr FW, Adamson IY, Young L. Promotion of pulmonary metastasis in mice by bleomycin-induced endothelial injury. Cancer Res 1986;46:891–897.

    PubMed  CAS  Google Scholar 

  13. Chau GY, Lui WY, Tsay SH, Chao Y, King KL, Wu CW. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study. Ann Surg Oncol 2006;13:1329–1337.

    Article  PubMed  Google Scholar 

  14. Ono T, Yamanoi A, Nazmy El, Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: meta analysis of three randomized controlled trials. Cancer 2001;91:2378–2385.

    Article  PubMed  CAS  Google Scholar 

  15. Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O’Reilly MS, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drugresistant cancer. Cancer Res 2000;60:1878–1886.

    PubMed  CAS  Google Scholar 

  16. Yu J, Liu H, Lei J, Tan W, Hu X, Zou G. Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytoher Res 2007;21:817–822.

    Article  CAS  Google Scholar 

  17. Yin X, Zhou J, Jie C, Xing D, Zhang Y. Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 2004;75:2233–2244.

    Article  PubMed  CAS  Google Scholar 

  18. Wang WJ, Li DJ, Li J, Zhou WJ. An 18. in vitro study on neuroprotective effects of serum containing Gengnianchun decoction and its main monomers against amyloid beta protein-induced cellular toxicity. J Chin Integr Med (Chin) 2010;8:67–73.

    Article  Google Scholar 

  19. Korbakis D, Scorilas A. Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12. Tumor Biol 2009;30:100–107.

    Article  CAS  Google Scholar 

  20. Sundblad AS, Tamayo R. Expression of MIB-1/KI-67and bcl-2 in gastric carcinoma. Relationship with clinico-pathological factors. Acta Gastroenterol Latinoam 1995;25:67–72.

    PubMed  CAS  Google Scholar 

  21. Xu AG, Li SG, Liu JH. Significance of apoptosis and expression of bcl-2 in gastric precarcinoma and cancer. Guangdong Med J (Chin) 1998;19:489–490.

    CAS  Google Scholar 

  22. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppression tumorigenesis and stimulates apoptosis in vivo. Nature 1997;385:637–640.

    Article  PubMed  CAS  Google Scholar 

  23. Qiu Z, Zhu J, Harms JS, Friedrichsen J, Splitter GA. Bovine herpesvirus VP22 induces apoptosis in neuroblastoma cells by upregulating the expression ratio of Bax to Bcl-2. Hum Gene Ther 2005;16:101–108.

    Article  PubMed  CAS  Google Scholar 

  24. Zheng XL, Sun HX, Liu XL, Chen YX, Qian BC. Astilbic acid induced COLO 205 cell apoptosis by regulating Bcl-2 and Bax expression and activating caspase-3. Acta Pharmacol Sin 2004;25:1090–1095.

    PubMed  CAS  Google Scholar 

  25. Bowen JM, Gibson RJ, Keefe DM, Cummins AG. Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology 2005;37:56–62.

    Article  PubMed  CAS  Google Scholar 

  26. Kok SH, Cheng SJ, Hong CY, Lee JJ, Lin SK, Kuo YS, et al. Norcantharidin induced apoptosis in oral cancer cells isassociated with an increase of proapoptotic to antiapoptotic. Cancer Lett 2005;217:43–52.

    Article  PubMed  CAS  Google Scholar 

  27. Piette J, Neel H, Maréchal V. Mdm2: keeping p53 under control. Oncogene 1997;15:1001–1010.

    Article  PubMed  CAS  Google Scholar 

  28. Vousden KH, Lu X. Live or let die: the cell’s response to p53. Nat Rev Cancer 2002;2:594–604.

    Article  PubMed  CAS  Google Scholar 

  29. Lowe SW, Ruley HE, Jacks T, Housman DE. P53 dependent apoptosis modulates the cytoxicity of anticancer agents. Cell 1993;74:957–967.

    Article  PubMed  CAS  Google Scholar 

  30. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, et al. Immediate early up-regulation of bax expression by p53 but not TGFb1: a paradigm for distinct apoptotic pathways. Oncogene 1994;9:1791–1798.

    PubMed  CAS  Google Scholar 

  31. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor P53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799–1805.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lei Dong  (董 蕾).

Additional information

Supported by “13115” Program of Shaanxi Province (No. 2007ZDKG-73)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dang, Xy., Dong, L., Shi, Ht. et al. Effects of serum containing Chinese medicine Sanpi Pingwei (散癖平胃) formula on proliferation and apoptosis of human SGC-7901 cells. Chin. J. Integr. Med. 19, 119–126 (2013). https://doi.org/10.1007/s11655-012-1208-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-012-1208-6

Keywords

Navigation